Effectiveness and cost of contraception in France (FACET study): a cohort study from the French National Healthcare Insurance Database.

Objective: To assess the effectiveness and costs associated with contraceptive methods based on real-world data in France.

Study Design: A cross-sectional cohort study based on data from a representative sample of the French National Healthcare Insurance Database (Echantillon Généralistes des Bénéficiaires (EGB)) was performed between January 1st 2006 and December 31st 2012. Women aged 15 years or older and users of at least one reimbursed contraceptive method between January 1st 2012 and December 31st 2012 were selected.

Ready-to-use pre-filled syringes of atropine for anaesthesia care in French hospitals - a budget impact analysis.

Background: Patient safety is improved by the use of labelled, ready-to-use, pre-filled syringes (PFS) when compared to conventional methods of syringe preparation (CMP) of the same product from an ampoule. However, the PFS presentation costs more than the CMP presentation.

Objective: To estimate the budget impact for French hospitals of switching from atropine in ampoules to atropine PFS for anaesthesia care.

Percutaneous vertebroplasty in vertebral metastases from breast cancer: interest in terms of pain relief and quality of life.

Percutaneous vertebroplasty (PV) is a therapeutic option in patients with vertebral metastases (VM). However its efficacy in pain relief, improvement in quality of life and safety in patients with VM from breast cancer has not been reported. We present a longitudinal retrospective study of 31 consecutively treated female patients with VM from breast cancer where 88 vertebrae were treated in 44 sessions of PV, in which osteolytic, osteoblastic and mixed lesions were recorded.

The association between asthma control, health care costs, and quality of life in France and Spain.

Background: Current asthma management guidelines are based on the level of asthma control. The impact of asthma control on health care resources and quality of life (QoL) is insufficiently studied. EUCOAST study was designed to describe costs and QoL in adult patients according to level of asthma control in France and Spain.

[French adaptation of a mammography questionnaire (MGQ)].

The benefit to be derived from mammographic examinations is conditioned by subjects' compliance with regular examinations, and this compliance depends partly on psychological aspects of the experience and the subject's perception of the examination. A mammography can indeed be unpleasant, whether physically or psychologically, and it is important to alleviate and minimise this. The MammoGraphy Questionnaire (MGQ) developed and validated in Norway, explores perceptions of mammography and specifically addresses interactions with radiology health professionals, the organisation of the examination, and the physical environment in which it occurs.

[Reflexion on innovation diffusion factors: the case of Herceptin].

New innovating cancer therapies are becoming available on the market. Because medical innovations put a serious financial burden on healthcare system, it is important to understand their diffusion. To analyze this process of diffusion, the molecule trastuzumab (Herceptin) provided by Roche Laboratories was chosen.